Paravertebral dexmedetomidine as an adjuvant to ropivacaine protects against independent lung injury during one-lung ventilation: a preliminary randomized clinical trial

Overview of attention for article published in BMC Anesthesiology, June 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 26,025 followers.

Paravertebral #dexmedetomidine as an adjuvant to ropivacaine protects against independent lung injury during #OneLungVentilation @BMC_series | #ECM https://t.co/rknD1HXngr

Reply Repost Favourite

RT @dipi1_con: Paravertebral #Dexmedetomidine as an adjuvant to #Ropivacaine protects against independent #Lung injury during one-lung #V…

Reply Repost Favourite

RT @dipi1_con: Paravertebral #Dexmedetomidine as an adjuvant to #Ropivacaine protects against independent #Lung injury during one-lung #V…

Reply Repost Favourite

RT @dipi1_con: Paravertebral #Dexmedetomidine as an adjuvant to #Ropivacaine protects against independent #Lung injury during one-lung #V…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.